Retention of viability, cytotoxicity, and response to IL-2, IL-15, or IFN-α by human NK cells after CD107a degranulation
Open Access
- 23 February 2009
- journal article
- host defense-and-pathophysiology
- Published by Oxford University Press (OUP) in Journal of Leukocyte Biology
- Vol. 85 (5) , 871-876
Abstract
NK cells represent a critical component of the host innate immune response to viral infection and tumor transformation. Nevertheless, the fate of recently degranulated NK cells subsequent to a primary target cell interaction remains largely unexplored. Here, we investigated the long-term viability and killing potential of human NK cells following target cell lysis using live-sorting of CD107a-degranulated NK cells. We observed that sorted CD107a+ NK cells exhibited continued lytic potential against a wide variety of target cells, including tumor and virally infected target cells. CD107a-positive- and CD107a-negative-sorted NK cells displayed similar long-term viability, killing potential, and response to inflammatory cytokines such as IL-2, IL-15, and IFN-α. Interestingly, we observed that the CD107a signature is remarkably stable over time and that recently degranulated NK cells exhibit an amplification of CD107 expression immediately following a target cell interaction. Together, our data expand previous data showing that NK cells retain the capacity to kill multiple target cells in succession and reveal that NK viability, cytotoxicity, and response to inflammatory cytokines are not altered following a primary target cell interaction. Overall, our data argue for the strength of the NK cell compartment in the continuous surveillance of tumor and virally infected cells in the body and highlight the use of using CD107a expression as a stable marker for NK cytotoxicity.Keywords
Funding Information
- The Wistar Institute Flow Cytometry Core Facility
This publication has 21 references indexed in Scilit:
- Conferral of Enhanced Natural Killer Cell Function by KIR3DS1 in Early Human Immunodeficiency Virus Type 1 InfectionJournal of Virology, 2008
- The CD107 mobilization assay: viable isolation and immunotherapeutic potential of tumor-cytolytic NK cellsLeukemia, 2005
- Interleukin-2 activated NK cells do not use the CD95L- and TRAIL-pathways in the rapid induction of apoptosis of rat colon carcinoma CC531s cellsImmunobiology, 2003
- Activating Receptors and Coreceptors Involved in Human Natural Killer Cell-Mediated CytolysisAnnual Review of Immunology, 2001
- CORRELATION OF HUMAN CD56+CELL CYTOTOXICITY AND IFN-γ PRODUCTIONCytokine, 2001
- NATURAL KILLER CELLS IN ANTIVIRAL DEFENSE: Function and Regulation by Innate CytokinesAnnual Review of Immunology, 1999
- NK CELL RECEPTORSAnnual Review of Immunology, 1998
- Killer cell inhibitory receptors: diversity, specificity, and functionImmunological Reviews, 1997
- Natural killer cell stimulatory factor (NKSF) or interleukin-12 is a key regulator of immune response and inflammationProgress in Growth Factor Research, 1992
- Recycling and target binding capacity of human natural killer cells.Journal of Experimental Medicine, 1981